ARCH Venture Fund XII, L.P.
CIK
1906837
13D Filings
6
Companies
4
Latest Filing
May 6, 2026, 04:26 PM
Filing History
Company | % Owned | Type | Filed | |
|---|---|---|---|---|
Seaport Therapeutics, Inc. | 11.90% | NEW | May 6, 2026, 04:26 PM | |
Neumora Therapeutics, Inc. NMRA | 18.70% ▼ -2.00% | Amendment | Apr 1, 2026, 04:10 PM | |
Metsera, Inc. | 0.00% ▼ -25.50% | Amendment | Nov 14, 2025, 06:22 PM | |
Neumora Therapeutics, Inc. NMRA | 20.70% | Amendment | Oct 29, 2025, 07:07 PM | |
Prime Medicine, Inc. PRME | 10.40% | Amendment | Aug 11, 2025, 09:48 PM | |
Metsera, Inc. | 25.50% | NEW | Feb 10, 2025, 09:30 PM | |
Rows:
20
1–6 of 6
1